OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer
Jinyan Wang, Dongmei Qin, Zhong-Hua Tao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Histone lactylation: from tumor lactate metabolism to epigenetic regulation
Xiaoning Yu, Jing Yang, Jin Xu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1833-1854
Open Access | Times Cited: 16

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14

Novel targets for gastric cancer: The tumor microenvironment (TME), N6-methyladenosine (m6A), pyroptosis, autophagy, ferroptosis and cuproptosis
Peizheng Yang, Wanting Yang, Wei Zhong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114883-114883
Open Access | Times Cited: 20

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies
Chenbin Bian, Zhuangzhuang Zheng, Jing Su, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20

The effect of lipid metabolism on cuproptosis-inducing cancer therapy
Yue Zhong, Wei Zeng, Yongbo Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116247-116247
Open Access | Times Cited: 6

Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer
Wanqian Liao, Yu Wang, Rui Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1089-1089
Open Access

Preoperative liquid biopsy transcriptomic panel for risk assessment of lymph node metastasis in T1 gastric cancer
Pingan Ding, Jiaxiang Wu, Haotian Wu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Mechanism of metal ion-induced cell death in gastrointestinal cancer
Muhua Luan, Zhaotian Feng, Wenshuai Zhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116574-116574
Open Access | Times Cited: 4

Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

The Role of Cuproptosis Key Factor FDX1 in Gastric Cancer
Qiqi Zhao, Miao Yu, Xueqin Du, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 26, Iss. 1, pp. 132-142
Closed Access | Times Cited: 3

Single‐cell analysis uncovers high‐proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer
Wenjia Zhang, Xiaojing Wang, Jiaxing Dong, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 2

FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma
Xian-Ze Xie, Lei Zuo, Wei Huang, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 6, pp. 1803-1824
Open Access | Times Cited: 2

The functions of cuproptosis in gastric cancer: therapy, diagnosis, prognosis
Zhiqin Zhang, Shenhua Shao, Hao Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117100-117100
Open Access | Times Cited: 2

A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma
Shiyong Xin, Ruixin Li, Junjie Su, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 13925-13942
Closed Access | Times Cited: 5

Establishment of patient-derived organoids and a characterization based drug discovery platform for treatment of gastric cancer
Guo Chen, Ruidong Han, Li Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma
Bailu Yang, Fukai Wen, Yifeng Cui
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 20
Open Access | Times Cited: 1

Immunotherapy for gastric cancer: Advances and challenges
Pei Zhang, Chenyan Zhang, M Kellis, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1

A cuproptosis-related signature for predicting the prognosis of gastric cancer
Chunmei He, Hao Zhang, Zehao Guo, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 146-164
Open Access | Times Cited: 3

Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer
Jiazheng Li, Can Kong, Wei Song, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1631-1652
Open Access | Times Cited: 3

Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer
Qian Li, Long-Kuan Yin
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 10, pp. 373-399
Open Access | Times Cited: 2

A prognostic model established using bile acid genes to predict the immunity and survival of patients with gastrointestinal cancer
Wu Xin, Peifa Liu, Qing Wang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4594-4609
Closed Access

Page 1 - Next Page

Scroll to top